# Clinical and economic implications of increased out-of-pocket insulin costs

Sanjay Basu, Seth A. Berkowitz, Kasia J. Lipska

Importance: As out-of-pocket insulin costs undergo scrutiny for regulatory action, policymakers have sought to identify the clinical and economic consequences of increased out-of-pocket insulin costs.

Objective: To test the hypothesis that increased out-of-pocket insulin prices are related to significantly increased odds of adverse clinical outcomes from diabetes mellitus, and associated excess healthcare spending. Secondarily, to test the hypothesis that such relationships are more present with insulin than with other common diabetes medications. 

Design: Secondary analyses of administrative claims data (years 2003-2016, analyzed in April 2019. 

*s.basu@imperial.ac.uk
